Unitree Robotics surged 629% in its Shanghai STAR Market debut, opening at 1,100 yuan against an IPO price of 150.8 yuan. As the first humanoid robot manufacturer listed on a mainland Chinese exchange, the company’s strong entry highlights high investor interest in robotics but brings risks related to market volatility and competitive pressure.
Unitree Robotics, a Hangzhou-based humanoid robot manufacturer, made a powerful debut on the Shanghai Stock Exchange’s technology-focused STAR Market on Wednesday. The company's shares opened at 1,100 yuan, marking a 629% increase from its initial public offering (IPO) price of 150.8 yuan per share. This listing represents a landmark moment for the sector, as Unitree is the first general-purpose humanoid robot maker to go public on a mainland Chinese exchange.
The IPO successfully raised approximately 6.1 billion yuan, equivalent to about US$904 million, reflecting high investor confidence. The offering saw immense demand from retail investors, with the retail portion oversubscribed more than 5,500 times. This enthusiasm underscores the growing strategic importance of the robotics industry, which is a major focus area for Chinese technology investment.
From a financial perspective, Unitree reported 2025 revenue of approximately 1.7 billion yuan and has shown profitability. Strategic investors, including technology giant Tencent and AI startup DeepSeek, were involved in the offering, which further boosted market sentiment. The company’s valuation stood at approximately 61 billion yuan before trading commenced.
While the listing was successful, investors are closely watching the stock for signs of stability. As with many high-profile tech IPOs, initial trading has been characterized by sharp volatility, with some price pullbacks observed from the opening high. The company's future performance is heavily tied to its ability to scale research and development efforts amid intense industry competition.
Key risks for investors to track include the potential for increased competition, which could put pressure on the company's competitive advantage over time. Additionally, the high valuation reflects expectations for rapid future growth, which may be sensitive to shifts in global trade policies and domestic economic conditions. As the company continues to navigate the public market, the long-term impact of its R&D strategies and ability to maintain profit margins will be important factors for shareholders to monitor.